To study the in vivo effect of FASN inhibition on endothelial barrier function in obesity, we next determined alterations in vascular permeability by EBD assay, lung wet-to-dry (W/D) ratio, and BALF protein concentration. The gene discussed is FASN; the disease is obesity due to melanocortin 4 receptor deficiency.